Skip to main content

SGS BioPharm Day 2016

In this talk, we explore the benefit of M&S in the execution of a Phase 1 trial. The case study presented shows a biological for which PK was very difficult to predict up front. Using M&S, it became possible to decide the next dosing, as well as when to stop the Phase1 trial.

See also the SGS event page to subscribe to future events. Other talks are available at CleverCast.

How can we help you?